Robert Michael Floyd - 08 Jun 2021 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Operating Officer
Signature
/s/ Michael Floyd by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
08 Jun 2021
Net transactions value
$0
Form type
4
Filing time
10 Jun 2021, 17:09:21 UTC
Next filing
22 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Units Award $0 +8,127 $0.000000 8,127 08 Jun 2021 Common Stock 8,127 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death.